Gene · 3459
Papers3,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target. | Cancers (Basel) | 2023 | 37958417 | PubTator, text mining | PubMed |
| Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer. | Front Oncol | 2023 | 37941546 | PubTator, text mining | PubMed |
| A pig model of chronic hepatitis E displaying persistent viremia and a downregulation of innate immune responses in the liver. | Hepatol Commun | 2023 | 37938097 | PubTator, text mining | PubMed |
| Lipin-2 regulates the antiviral and anti-inflammatory responses to interferon. | EMBO Rep | 2023 | 37929625 | PubTator, text mining | PubMed |
| Next generation sequencing uncovers multiple miRNAs associated molecular targets in gallbladder cancer patients. | Sci Rep | 2023 | 37925508 | PubTator, text mining | PubMed |
| MICa/b-dependent activation of natural killer cells by CD64+ inflammatory type 2 dendritic cells contributes to autoimmunity. | EMBO J | 2023 | 37916875 | PubTator, text mining | PubMed |
| Advancements in Understanding Gastric Cancer: A Comprehensive Review. | Cureus | 2023 | 37900456 | PubTator, text mining | PubMed |
| Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis. | Cancers (Basel) | 2023 | 37894474 | PubTator, text mining | PubMed |
| TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. | Biomedicines | 2023 | 37893178 | PubTator, text mining | PubMed |
| Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death? | Biomedicines | 2023 | 37893166 | PubTator, text mining | PubMed |
| B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C). | Mol Cell Pediatr | 2023 | 37891416 | PubTator, text mining | PubMed |
| Metabolic and senescence characteristics associated with the immune microenvironment in non-small cell lung cancer: insights from single-cell RNA sequencing. | Aging (Albany NY) | 2023 | 37889543 | PubTator, text mining | PubMed |
| "Input/output cytokines" in epidermal keratinocytes and the involvement in inflammatory skin diseases. | Front Immunol | 2023 | 37881433 | PubTator, text mining | PubMed |
| Advancements in CRISPR screens for the development of cancer immunotherapy strategies. | Mol Ther Oncolytics | 2023 | 37876793 | PubTator, text mining | PubMed |
| CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy. | Immunooncol Technol | 2023 | 37876518 | PubTator, text mining | PubMed |
| ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer. | bioRxiv | 2023 | 37873189 | PubTator, text mining | PubMed |
| Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia. | Oncogene | 2023 | 37872214 | PubTator, text mining | PubMed |
| The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes. | Front Endocrinol (Lausanne) | 2023 | 37867531 | PubTator, text mining | PubMed |
| Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma. | Aging (Albany NY) | 2023 | 37862109 | PubTator, text mining | PubMed |
| Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development. | Nat Commun | 2023 | 37845228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3459/papers?page=14